We've found
52,953 Cancer
clinical trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Status: Enrolling
Updated: 5/30/2012
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Status: Enrolling
Updated: 5/30/2012
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Status: Enrolling
Updated: 5/30/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study
Status: Enrolling
Updated: 9/12/2012
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Molecular Analysis of Thoracic Malignancies
Status: Enrolling,
Phase
Updated: 3/20/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Esophageal Protocol for Detection of Neoplasia in the Digestive Tract
Status: Enrolling
Updated: 1/12/2012
Click here to add this to my saved trials
Sarcoma, Alveolar Soft Part Clinical Trial
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Status: Enrolling,
Phase
I
Updated: 9/20/2017
Click here to add this to my saved trials
Hematology, Oncology, Psychiatry / Psychology Clinical Trial
Registry of Older Patients With Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Rectal Cancer Clinical Trial
Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer
Status: Enrolling
Updated: 8/17/2012
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Oncology Clinical Trial
ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 2/5/2013
Click here to add this to my saved trials
Oncology Clinical Trial
ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 2/5/2013
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Status: Enrolling
Updated: 7/7/2010
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
The Effect of Adding Intraoperative Regional Anesthesia on Cancer Recurrence in Patients Undergoing Lung Cancer Resection
Status: Enrolling
Updated: 8/18/2011
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
Status: Enrolling
Updated: 3/15/2011
Click here to add this to my saved trials
Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial
1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors
Status: Enrolling
Updated: 3/18/2013
Click here to add this to my saved trials
Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial
1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors
Status: Enrolling
Updated: 3/18/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Re-expression of ER in Triple Negative Breast Cancers
Status: Enrolling,
Phase
I, II
Updated: 11/18/2013
Click here to add this to my saved trials
Hormone Refractory Prostate Cancer Clinical Trial
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 2/1/2012
Click here to add this to my saved trials
Hormone Refractory Prostate Cancer Clinical Trial
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 2/1/2012
Click here to add this to my saved trials
Hormone Refractory Prostate Cancer Clinical Trial
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 2/1/2012
Click here to add this to my saved trials
Hormone Refractory Prostate Cancer Clinical Trial
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 2/1/2012
Click here to add this to my saved trials
Oncology Clinical Trial
SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin
Status: Enrolling
Updated: 3/4/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
Status: Enrolling
Updated: 5/20/2013
Click here to add this to my saved trials
Oncology Clinical Trial
RO4929097 And Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer
Status: Enrolling
Updated: 1/14/2013
Click here to add this to my saved trials
Oncology Clinical Trial
MEK Inhibitor AZD6244 and Cetuximab Treating Patients With Advanced or Refractory Solid Tumors That Cannot Be Removed By Surgery
Status: Enrolling
Updated: 10/28/2010
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Hematology, Oncology, Pharmacology / Toxicology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Clinical and Pathophysiological Investigations Into Erdheim Chester Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Radiofrequency Ablation After Breast Lumpectomy (ABLATE)
Status: Enrolling
Updated: 12/28/2012
Click here to add this to my saved trials
We've found
52,953 Cancer
clinical trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Updated: 2/29/2016
Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Updated: 5/30/2012
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Status: Enrolling
Updated: 5/30/2012
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Updated: 5/30/2012
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Status: Enrolling
Updated: 5/30/2012
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Updated: 5/30/2012
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Status: Enrolling
Updated: 5/30/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 9/12/2012
Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study
Status: Enrolling
Updated: 9/12/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/24/2014
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/24/2014
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/24/2014
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/24/2014
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/24/2014
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/24/2014
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/24/2014
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/24/2014
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/20/2018
Molecular Analysis of Thoracic Malignancies
Status: Enrolling,
Phase
Updated: 3/20/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/22/2013
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/22/2013
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/22/2013
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 1/12/2012
Esophageal Protocol for Detection of Neoplasia in the Digestive Tract
Status: Enrolling
Updated: 1/12/2012
Click here to add this to my saved trials
Sarcoma, Alveolar Soft Part Clinical Trial
Updated: 12/31/1969
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 8/28/2013
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 9/20/2017
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Status: Enrolling,
Phase
I
Updated: 9/20/2017
Click here to add this to my saved trials
Hematology, Oncology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Registry of Older Patients With Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Rectal Cancer Clinical Trial
Updated: 8/17/2012
Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer
Status: Enrolling
Updated: 8/17/2012
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/5/2013
ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 2/5/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/5/2013
ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 2/5/2013
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 7/7/2010
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Status: Enrolling
Updated: 7/7/2010
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 8/18/2011
The Effect of Adding Intraoperative Regional Anesthesia on Cancer Recurrence in Patients Undergoing Lung Cancer Resection
Status: Enrolling
Updated: 8/18/2011
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 3/15/2011
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
Status: Enrolling
Updated: 3/15/2011
Click here to add this to my saved trials
Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial
Updated: 3/18/2013
1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors
Status: Enrolling
Updated: 3/18/2013
Click here to add this to my saved trials
Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial
Updated: 3/18/2013
1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors
Status: Enrolling
Updated: 3/18/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/18/2013
Re-expression of ER in Triple Negative Breast Cancers
Status: Enrolling,
Phase
I, II
Updated: 11/18/2013
Click here to add this to my saved trials
Hormone Refractory Prostate Cancer Clinical Trial
Updated: 2/1/2012
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 2/1/2012
Click here to add this to my saved trials
Hormone Refractory Prostate Cancer Clinical Trial
Updated: 2/1/2012
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 2/1/2012
Click here to add this to my saved trials
Hormone Refractory Prostate Cancer Clinical Trial
Updated: 2/1/2012
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 2/1/2012
Click here to add this to my saved trials
Hormone Refractory Prostate Cancer Clinical Trial
Updated: 2/1/2012
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 2/1/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/4/2013
SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin
Status: Enrolling
Updated: 3/4/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/20/2013
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
Status: Enrolling
Updated: 5/20/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 1/14/2013
RO4929097 And Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer
Status: Enrolling
Updated: 1/14/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/28/2010
MEK Inhibitor AZD6244 and Cetuximab Treating Patients With Advanced or Refractory Solid Tumors That Cannot Be Removed By Surgery
Status: Enrolling
Updated: 10/28/2010
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 11/7/2012
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 11/7/2012
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 11/7/2012
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 11/7/2012
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 11/7/2012
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 11/7/2012
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Status: Enrolling
Updated: 11/7/2012
Click here to add this to my saved trials
Hematology, Oncology, Pharmacology / Toxicology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 12/31/1969
Clinical and Pathophysiological Investigations Into Erdheim Chester Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/28/2012
Radiofrequency Ablation After Breast Lumpectomy (ABLATE)
Status: Enrolling
Updated: 12/28/2012
Click here to add this to my saved trials